These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22284136)

  • 41. An assessment of the burden of migraine using the willingness to pay model.
    Hamelsky SW; Lipton RB; Stewart WF
    Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burden of skin diseases.
    Basra MK; Shahrukh M
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):271-83. PubMed ID: 19527100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating clinical rating scales for evidence-based dermatology: some basic concepts.
    Gupta MA; Johnson AM; Chren MM
    Dermatol Clin; 2005 Oct; 23(4):703-6. PubMed ID: 16112447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life issues in dermatology. Preface.
    Chen SC
    Dermatol Clin; 2012 Apr; 30(2):xiii. PubMed ID: 22284149
    [No Abstract]   [Full Text] [Related]  

  • 45. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessment of health related quality of life--part 3--preference based measures].
    Horowitz E; Hassidim H; Abadi-Korek I; Shemer J
    Harefuah; 2008 Nov; 147(11):914-9, 938. PubMed ID: 19264015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of psychosomatic factors in dermatologic pathology. A questionnaire research on the evaluation of dermatology specialists and general physicians].
    Meluzzi A; Goitre M; Alovisi V
    G Ital Dermatol Venereol; 1986; 121(4):253-60. PubMed ID: 3759133
    [No Abstract]   [Full Text] [Related]  

  • 49. Differences in willingness to pay for an extraction, a filling, and cleaning teeth at various levels of oral health-related quality of life, as measured by oral impacts on daily performance, among older adults in Singapore.
    Nair R; Yee R
    Singapore Dent J; 2016 Dec; 37():2-8. PubMed ID: 27916251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quality of life in dermatology. From measurement to practical implementation].
    Müller K; Karrer S; Apfelbacher C; Blome C; Berneburg M; Koller M
    Hautarzt; 2015 Apr; 66(4):287-96; quiz 297-8. PubMed ID: 25822586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life.
    Finlay AY; Salek MS; Abeni D; Tomás-Aragonés L; van Cranenburgh OD; Evers AW; Jemec GB; Linder D; Manolache L; Marrón SE; Prinsen CA; Susitaival P; Chernyshov PV;
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):424-431. PubMed ID: 27684717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermatology. Positioned for health care reform.
    Lober CW
    Arch Dermatol; 1996 Sep; 132(9):1065-7. PubMed ID: 8795547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilities and quality-adjusted life years.
    Torrance GW; Feeny D
    Int J Technol Assess Health Care; 1989; 5(4):559-75. PubMed ID: 2634630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Willingness-to-pay and Time Trade-off: The Burden of Disease in Patients with Benign Hyperpigmentation.
    Maymone MBC; Rajanala S; Widjajahakim R; Secemsky E; Saade D; Vashi NA
    J Clin Aesthet Dermatol; 2019 May; 12(5):46-48. PubMed ID: 31320977
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study of the Children's Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria.
    Clayton TH; Clark SM; Britton J; Pavlov S; Radev S
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1436-7. PubMed ID: 17958869
    [No Abstract]   [Full Text] [Related]  

  • 56. Managing patients with delusional infestations in an integrated psychodermatology clinic is much more cost-effective than a general dermatology or primary care setting.
    Altaf K; Mohandas P; Marshall C; Taylor R; Bewley A
    Br J Dermatol; 2017 Aug; 177(2):544-545. PubMed ID: 27680511
    [No Abstract]   [Full Text] [Related]  

  • 57. Dermatology quality of life instruments: sorting out the quagmire.
    Chen SC
    J Invest Dermatol; 2007 Dec; 127(12):2695-6. PubMed ID: 18007683
    [No Abstract]   [Full Text] [Related]  

  • 58. The burden of skin disease: quality of life, economic aspects and social issues.
    Finlay AY
    Clin Med (Lond); 2009 Dec; 9(6):592-4. PubMed ID: 20095308
    [No Abstract]   [Full Text] [Related]  

  • 59. 10 years experience of the Dermatology Life Quality Index (DLQI).
    Lewis V; Finlay AY
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):169-80. PubMed ID: 15083785
    [No Abstract]   [Full Text] [Related]  

  • 60. Willingness to pay for a QALY: past, present and future.
    Mason H; Baker R; Donaldson C
    Expert Rev Pharmacoecon Outcomes Res; 2008 Dec; 8(6):575-82. PubMed ID: 20528368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.